Tag: New Drug
Case Studies
Life Sciences
A biopharma industry leader with potential candidates in a phase III trial for neurological and cardiovascular diseases was interested in...
Articles
Medical Devices & Diagnostics
The global costs of diabetes are estimated to reach $2 trillion by 2030. This is due to the increasing number of type...